These results suggest that PYK2 can modulate tumor angiogenesis through several mechanisms, and its ablation in the BC cells and/or in the TME can reduce the levels of certain proangiogenic factors and attenuate angiogenesis. The gene discussed is PTK2B; the disease is breast cancer.